In the face of efficacy and safety concerns, China becomes the world’s top exporter of coronavirus shots as logistics companies ramp up flights

hina, Singapore and Japan are providing medical gear, vaccines as the nation’s case figures hit new highs

One billion vaccine doses administered on Chinese mainland, huge garbage patch reappears on Tibetan Plateau

China launches crewed spacecraft Shenzhou-12, country’s Covid-19 vaccination reaches more than 900 million doses

More transmissible variants, low vaccination rates have seen some places feel the heat of the pandemic for the first time

By offering a helping hand, China is aiming to protect itself from the pandemic, while also trying to mend fences with its neighbor, experts say

The scramble to crank out enough shots to inoculate more than 1 billion Chinese involves multiple companies pursuing different strategies and building massive factories

Cutting-edge toripalimab utilizes a patient’s own immune system to fight cancer

Although three Covid-19 vaccines have been approved for emergency use in China, no clinical data involving people over the age of 59 have been made public

With 2 million doses of Sinovac and Pfizer-BioNTech shots on the way, city plans inoculation campaign starting Feb. 26

First 100,000 shots to commence around Lunar New Year next week with inoculations from BioNTech due in February and AstraZeneca later

Now that Covid-19 vaccines are winning approval, the hard part will be making billions of doses and shipping and storing them at super-cold temperatures

The vaccine stopped an average of 70% of participants from falling ill, an early analysis of the data show

World Economic Forum survey finds 26% of people wouldn’t be inoculated, citing rushed development, though 97% of Chinese would be receptive

Beijing has offered similar priority access to its vaccine to Pakistan and many other countries in an effort to further reinforce its clout

Trump administration threatens U.S. ban of ‘untrusted’ Chinese apps; TikTok to set up Irish data center and London global headquarters

Bristol-Myers Squibb, Novartis and AstraZeneca could have products fast-tracked by Chinese regulator